effects of topical ointment Myrtus communis on symptoms of internal hemorrhoid grade one and two
- Conditions
- hemorrhoid.Disease of anus and rectum, unspecified
- Registration Number
- IRCT201612278170N10
- Lead Sponsor
- Vice President of Research Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 54
Women have given birth for at least 4 weeks and up to 4 months from their delivery, either in the normal way of any cesarean section (including Nully Par and Multipar); women in post delivery period who have been diagnosed their hemorrhoids first and second degree with clinical symptoms and confirmed by the Surgeon General; women between 18-40 years; Women in the postpartum period whose hemorrhoids are not caused by systemic diseases such as hypertension; hemorrhoid symptomsfor at least more than 7 days; The ability to read and write.
Exclusion criteria: Use of Systemic steroid Drugs and non-steroidal anti-inflammatory drugs and analgesics and anti-hemorrhoid treatments (for a one month prior to the study) and the use of anticoagulant drugs; require surgical procedure for the treatment of hemorrhoids (a gastroenterologist confirmed by clinical testing and colonoscopy); women with problems such as abscesses, anorectal, fistula, tuberculosis, herpes, varicella, fungal infection (confirmed by clinical trials or colonoscopy); risk of gastrointestinal tract infectious inflammatory diseases or colorectal cancer (as the patient); The previous use of laser or the use of medication felebotonic to treat hemorrhoids a week before the study (as the patient); Delivery with vacuums or forceps and delivery of cesarean section with large ancision; the company in another intervention study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The mean score of the symptoms of hemorrhoids. Timepoint: Before intervention, 1, 2, 4 and 8 weeks after intervention. Method of measurement: (Colo-Rectal Evaluation of Clinical Therapeutics Scale) (CORECTS).;Quality of life score. Timepoint: Before intervention? 4 and 8 weeks after intervention. Method of measurement: The World Health Organization Quality of Life questionnaire of 26 questions (WHOQOL-BREF).
- Secondary Outcome Measures
Name Time Method The frequency of side events incidence. Timepoint: During 8 weeks after intervention. Method of measurement: The side events check list.;The patients satisfaction of received drug. Timepoint: 4 and 8 weeks after intervention. Method of measurement: The check list of satisfaction of received drug.